We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Severe DysphagiaWith Eosinophilic Esophagitis Pattern of Injury Related to Pembrolizumab Therapy.
- Authors
Barnett, James S.; Yu, Kevin K.; Rivera, Xavier Rivera; Bhatt, Asmeen
- Abstract
While immune checkpoint inhibitor (ICI) therapies are effective treatments for many cancers, ICI therapies are associated with immune-related adverse events.Wepresent a 67-year-old man with non--small cell lung carcinoma, who developed severe dysphagia with biopsies from an esophagogastroduodenoscopy showing histopathology consistent with eosinophilic esophagitis while on ICI maintenance therapy with pembrolizumab. The patient's symptoms worsened despite standard therapy. However, he had complete resolution of dysphagia symptoms once pembrolizumab was discontinued. While immune-related adverse events affecting the gastrointestinal system are increasingly recognized, ICI-associated eosinophilic esophagitis is a rare entity.
- Subjects
EOSINOPHILIC esophagitis; GASTROINTESTINAL system; IMMUNE checkpoint inhibitors; BIOPSY; COMBINATION drug therapy; DEGLUTITION disorders; EPIDEMIOLOGY; LUNG tumors; DIGESTIVE system endoscopic surgery; CANCER patients; WOUNDS &; injuries; HYPOKALEMIA
- Publication
ACG Case Reports Journal, 2024, Vol 11, Issue 1, p1
- ISSN
2326-3253
- Publication type
Article
- DOI
10.14309/crj.0000000000001252